Long non-coding RNA ASBEL promotes osteosarcoma cell proliferation, migration, and invasion by regulating microRNA-21

Radiotherapy in the Treatment of Primary Osteosarcoma – a Single Center Experience

(2018) Susanne Oertel et al.   TUMORI

Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth

(2017) Jaya Sangodkar et al.   JOURNAL OF CLINICAL INVESTIGATION

Arctigenin inhibits triple-negative breast cancers by targeting CIP2A to reactivate protein phosphatase 2A

(2017) Qiuyue Huang et al.   ONCOLOGY REPORTS

miR-150 is downregulated in osteosarcoma and suppresses cell proliferation, migration and invasion by targeting ROCK1

(2017) Chang-Hui Li et al.   Oncology Letters

NNMT Silencing Activates Tumor Suppressor PP2A, Inactivates Oncogenic STKs, and Inhibits Tumor Forming Ability

(2016) Kamalakannan Palanichamy et al.   CLINICAL CANCER RESEARCH

3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo

(2016) Ko-Hsiu Lu et al.   FOOD AND CHEMICAL TOXICOLOGY

ASBEL–TCF3 complex is required for the tumorigenicity of colorectal cancer cells

(2016) Kenzui Taniue et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Long noncoding RNAs in the progression, metastasis and prognosis of osteosarcoma

(2016) Zuozhang Yang et al.   Cell Death & Disease

Long Noncoding RNAs as New Architects in Cancer Epigenetics, Prognostic Biomarkers, and Potential Therapeutic Targets

(2015) Didier Meseure et al.   Biomed Research International

Long noncoding RNAs: a potential novel class of cancer biomarkers

(2015) Aliaksandr A. Yarmishyn et al.   Frontiers in Genetics

MicroRNAs and Potential Targets in Osteosarcoma: Review

(2015) Valerie B. Sampson et al.   Frontiers in Pediatrics

Regulation of Transcription by Long Noncoding RNAs

(2014) Roberto Bonasio et al.   Annual Review of Genetics

Significance of MTA1 in the molecular characterization of osteosarcoma

(2014) Sung Sun Kim et al.   CANCER AND METASTASIS REVIEWS

APEX1 Gene Amplification and Its Protein Overexpression in Osteosarcoma: Correlation with Recurrence, Metastasis, and Survival

(2014) Jilong Yang et al.   TECHNOLOGY IN CANCER RESEARCH & TREATMENT

Molecular mechanisms of chemoresistance in osteosarcoma (Review)

(2014) HONGTAO HE et al.   Oncology Letters

ASBEL, an ANA/BTG3 antisense transcript required for tumorigenicity of ovarian carcinoma

(2013) Satoshi Yanagida et al.   Scientific Reports

Bioinformatics Tools and Novel Challenges in Long Non-Coding RNAs (lncRNAs) Functional Analysis

(2011) Letizia Da Sacco et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

MicroRNA miR-21 Regulates the Metastatic Behavior of B16 Melanoma Cells

(2011) Chuan He Yang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Clinical, therapeutic and prognostic features of osteosarcoma of the jaws – Experience of 36 cases

(2011) Peer Wolfgang Kämmerer et al.   JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY

Molecular Mechanisms of Long Noncoding RNAs

(2011) Kevin C. Wang et al.   MOLECULAR CELL

Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma

(2011) Georges Maire et al.   Cancer Genetics

BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer

(2009) S. Majid et al.   CARCINOGENESIS

Evolution and Functions of Long Noncoding RNAs

(2009) Chris P. Ponting et al.   CELL

The mammalian anti-proliferative BTG/Tob protein family

(2009) G. Sebastiaan Winkler   JOURNAL OF CELLULAR PHYSIOLOGY

Identification of miR-21 targets in breast cancer cells using a quantitative proteomic approach

(2009) Yi Yang et al.   PROTEOMICS

Deficiency of antiproliferative family protein Ana correlates with development of lung adenocarcinoma

(2008) Mitsuhiro Yoneda et al.   CANCER SCIENCE